Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 26.00M $325.26M June 30, 2015
PRIMECAP Management Company 19.71M $246.53M June 30, 2015
Vanguard 9.94M $124.38M June 30, 2015
First Trust Advisors 9.73M $121.68M June 30, 2015
BlackRock Fund Advisors 9.29M $116.21M June 30, 2015
HealthCor Management 9.20M $66.88M June 30, 2011
STATE STREET CORPORATION 5.41M $67.66M June 30, 2015
Ulys 5.17M $28.93M Dec. 31, 2011
JPMORGAN CHASE & CO 4.55M $50.01M March 31, 2015
BVF 4.21M $44.93M Sept. 30, 2012
Inves 4.13M $64.09M Dec. 31, 2014
HealthCor Management 4.00M $46.20M June 30, 2013
Federated Investors 3.58M $44.75M June 30, 2015
BlackRock Institutional Trust Company, N.A. 3.22M $40.22M June 30, 2015
Franklin Resources 3.04M $38.93M June 30, 2014
Artal Group S.A. 3.00M $22.23M Dec. 31, 2012
Deerfield Management Company 2.94M $33.95M June 30, 2013

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M